Is it true that the pharmaceutical companies are hurdle in discovery of cure for PD. Some skeptics believe that FDA is helping them in safeguarding their interests and both lay in the same bed.
the Parkinson’s disease market is set to expand to $3.2 billion by 2021, game-changing treatments will not be available for the foreseeable future, according to business intelligence provider GBI Research.
The market for anti-Parkinson drugs is concentrated with a few large players dominating the market. Major players in the market are AbbVie, GlaxoSmithKline, Novartis, Zambon Pharmaceuticals and others.
The current work revolves around a 100 year drug Levodopa. Many new levodopa formulations are expected to enter the market by 2021, each designed to improve off-episodes in advanced Parkinson’s disease patients by providing continuous drug administration.
Keeping in view this scenario, the cure does not seem to arrive in our lives